In 2012 we raised more than £2.5m in order to deliver the UK's first National Centre for Bowel Research (NBRC). A centrepiece of the NBRC is its Human Tissue Laboratory which ranks among the best facilities of its type possibly worldwide.

One of the main research projects within the laboratory was seed funded by us to investigate pain in Inflammatory Bowel Disease (IBD). This work has gone on to deliver significant firsts in assisting our understanding of pain, including the role of serotonin, and of a sodium channel called Nav 1.9.

It has also gone on to deliver funding from a wide variety of national and international sources, including the Dr Hadwen Trust for Humane Research, The Royal College of Surgeons (GB), The Biotechnology and Biological Sciences Research Council, Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Crohn's and Colitis Foundation of Canada (DR), Wellcome Trust and The Medical Research Council.

A recent paper from the NBRC team was published in Jan 2018 in GUT. As a result of their work we are confident that new therapies for pain will be delivered within the next 5 - 10 years, meaning that patients will not have to resort to opiods such as morphine as the only relief.

To read more about our research into pain in Inflammatory Bowel Disease please visit our Bowel Disease Research page.